Provaidya LLC, is a biopharmaceutical startup company organized around development of innovative therapies for neurodegenerative diseases, specifically to promote translation of rationally designed novel agents developed as therapeutics for Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases in academic settings. Seeking to address the spectrum of neurodegenerative diseases, Provaidya has taken first steps with evaluating novel mechanism based peptide inhibitors in models of Alzheimer's disease and Multiple Sclerosis.
